Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population

Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population

Bibliographic Details
Main Authors:	Silva, Sarah Pagliarini- e-, Santos, Bruna Cunha, de Figueiredo Pereira, Elizangela Mendes, Ferreira, Mari Ellen, Baraldi, Elaine Cristina, Sell, Ana Maria, Visentainer, Jeane Eliete Laguila
Format:	Online
Language:	English
Published:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552438/

Similar Items

Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview
by: de Freitas, Renata Mendes, et al.
Published: (2015)

HLA Haplotypes and Genotypes Frequencies in Brazilian Chronic Periodontitis Patients
by: Sippert, Emília Ângela, et al.
Published: (2015)

Mouse models of myeloproliferative neoplasms: JAK of all grades
by: Li, Juan, et al.
Published: (2011)

The JAK2 gene as a protagonist in chronic myeloproliferative neoplasms
by: de Freitas, Renata Mendes, et al.
Published: (2013)

JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms
by: Bellido, Mar, et al.
Published: (2012)

Biology and Clinical Management of Myeloproliferative Neoplasms and Development of the JAK Inhibitor Ruxolitinib
by: Mascarenhas, J, et al.
Published: (2012)

The role of the Exon 13 G571S JAK2 mutation in myeloproliferative neoplasms
by: Bahar, Burak, et al.
Published: (2016)

Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
by: Čokić, Vladan P., et al.
Published: (2015)

Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm
by: Hassan, Abdulaziz, et al.
Published: (2015)

Association of Duffy Blood Group Gene Polymorphisms with IL8 Gene in Chronic Periodontitis
by: Sippert, Emília Ângela, et al.
Published: (2013)

Letter Concerning: “Genotyping for Kidd, Kell, Duffy, Scianna, and RHCE Blood Group Antigens Polymorphisms in Jiangsu Chinese Han”
by: Colli, Cristiane Maria, et al.
Published: (2015)

Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies
by: Passamonti, Francesco, et al.
Published: (2011)

JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms
by: Gäbler, Karoline, et al.
Published: (2013)

The Influence of Interleukin 17A and IL17F Polymorphisms on Chronic Periodontitis Disease in Brazilian Patients
by: Zacarias, Joana Maira Valentini, et al.
Published: (2015)

Somatic mutations of calreticulin in a Brazilian cohort of patients with myeloproliferative neoplasms
by: Machado-Neto, João Agostinho, et al.
Published: (2015)

The Hematopoietic Niche in Myeloproliferative Neoplasms
by: Schmitt-Graeff, Annette H., et al.
Published: (2015)

Guidelines for the management of myeloproliferative neoplasms
by: Choi, Chul Won, et al.
Published: (2015)

Calreticulin Mutations in Myeloproliferative Neoplasms
by: Lavi, Noa
Published: (2014)

Apoptosis deregulation in myeloproliferative neoplasms
by: Tognon, Raquel, et al.
Published: (2013)

Philadelphia-negative chronic myeloproliferative neoplasms
by: Bittencourt, Rosane Isabel, et al.
Published: (2012)

Genetic–pathologic characterization of myeloproliferative neoplasms
by: Kim, Yonggoo, et al.
Published: (2016)

JAK2 V617F-Dependent Upregulation of PU.1 Expression in the Peripheral Blood of Myeloproliferative Neoplasm Patients
by: Irino, Tamotsu, et al.
Published: (2011)

Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms
by: Nakaya, Y, et al.
Published: (2011)

Abdominal venous thrombosis presenting in myeloproliferative neoplasm with JAK2 V617F mutation: a case report
by: Pemmaraju, Naveen, et al.
Published: (2012)

The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population
by: Ohyashiki, Junko H, et al.
Published: (2012)

Splanchnic vein thrombosis, the onset manifestation in JAK positive Chronic Myeloproliferative Disorders Neoplasms
by: Vladareanu, AM, et al.
Published: (2011)

Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms
by: Stein, Brady L., et al.
Published: (2011)

Transient ischemic attacks as the first presentation of JAK2-V617F positive chronic myeloproliferative neoplasm
by: Kalala, Fani, et al.
Published: (2012)

Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms
by: Kim, Hye-Ran, et al.
Published: (2013)

Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha
by: Lane, Steven W., et al.
Published: (2013)

mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms
by: Bogani, Costanza, et al.
Published: (2013)

Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation
by: Bennemann, Karla, et al.
Published: (2012)

Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice
by: Shi, Kaiyao, et al.
Published: (2014)

Improved Diagnosis of the Transition to JAK2 V617F Homozygosity: The Key Feature for Predicting the Evolution of Myeloproliferative Neoplasms
by: Gonzalez, Mariana Selena, et al.
Published: (2014)

The allele burden of JAK2 V617F can aid in differential diagnosis of Philadelphia Chromosome-Negative Myeloproliferative Neoplasm
by: Park, Sang Hyuk, et al.
Published: (2013)

Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1
by: Tefferi, Ayalew
Published: (2009)

JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines
by: Nauroy, P, et al.
Published: (2014)

Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms
by: Deshpande, Anagha, et al.
Published: (2011)

Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms
by: Kanwaljeet Singh, et al.
Published: (2018-01-01)

The Importance of Identification of M-BCRABL Oncogene and JAK2V617F Mutation in Myeloproliferative Neoplasms
by: Szántó Annamária, et al.
Published: (2014-04-01)